Words of Wisdom:

"War can be defined as a struggle of an individual or group to uphold their beliefs or current position. " - Giang

P-Selectin (Granule Membrane Protein 140) Market Share, Size, Definition, Treatment, Syndrome, Pipeline Review, H1 2016

  • Date Submitted: 10/17/2016 12:28 AM
  • Flesch-Kincaid Score: -7.2 
  • Words: 1170
  • Essay Grade: no grades
  • Report this Essay
P-Selectin (Granule Membrane Protein 140) Market Share,
Definition, Treatment, Causes, Pipeline Review, H1 2016 by
Radiant Insights
Summary
Global Markets Direct's, 'P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent GranuleExternal Membrane Protein or CD62P) - Pipeline Review, H1 2016', provides in depth analysis on P-Selectin
(Granule Membrane Protein 140 or Platelet Activation Dependent Granule-External Membrane Protein or CD62P)
targeted pipeline therapeutics.
The report provides comprehensive information on the P-Selectin (Granule Membrane Protein 140 or Platelet
Activation Dependent Granule-External Membrane Protein or CD62P), targeted therapeutics, complete with
analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and
molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases. Additionally, the report provides an
overview of key players involved in P-Selectin (Granule Membrane Protein 140 or Platelet Activation Dependent
Granule-External Membrane Protein or CD62P) targeted therapeutics development and features dormant and
discontinued projects.
Browse Complete Summary Click Here @ http://www.radiantinsights.com/research/p-selectin-granulemembrane-protein-140
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and
nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's
proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third party sources.
Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set...

Comments

Express your owns thoughts and ideas on this essay by writing a grade and/or critique.

  1. No comments